Page last updated: 2024-11-03

prazosin and Dissociation

prazosin has been researched along with Dissociation in 2 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research Excerpts

ExcerptRelevanceReference
"Patients with dissociative disorders do not respond well to standard exposure therapy, and few psychopharmacologic trials exist."1.42Psychopharmacologic treatment of dissociative fugue and PTSD in an Ethiopian refugee. ( Liu-Barbaro, D; Stein, M, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu-Barbaro, D1
Stein, M1
Reardon, CL1
Factor, RM1

Other Studies

2 other studies available for prazosin and Dissociation

ArticleYear
Psychopharmacologic treatment of dissociative fugue and PTSD in an Ethiopian refugee.
    The Journal of clinical psychiatry, 2015, Volume: 76, Issue:7

    Topics: Adrenergic alpha-1 Receptor Antagonists; Comorbidity; Dissociative Disorders; Ethiopia; Humans; Male

2015
Bizarre behavior in a patient treated with prazosin for PTSD.
    The American journal of psychiatry, 2008, Volume: 165, Issue:6

    Topics: Adrenergic alpha-Antagonists; Adult; Awareness; Combat Disorders; Dissociative Disorders; Dreams; Gu

2008